可善挺-话题@MedSci

#可善挺#

3篇内容 | 861人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1337847, encodeId=5fcb133e847e6, content=<a href='/topic/show?id=165638446af' target=_blank style='color:#2F92EE;'>#可善挺#</a>, objectTitle=可善挺项目, objectType=article, longId=204541, objectId=70af204541a5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=70af204541a5, replyNumber=0, likeNumber=33, createdTime=2020-12-17, rootId=0, userName=ms6980045490879608, userId=36f02500138, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=70af204541a5, moduleTitle=可善挺项目, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=70af204541a5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1337846, encodeId=f0b7133e84627, content=<a href='/topic/show?id=165638446af' target=_blank style='color:#2F92EE;'>#可善挺#</a>, objectTitle=FDA：批准司库奇尤单抗（可善挺）获治疗中轴型脊柱关节炎, objectType=article, longId=196033, objectId=9dbe1960331f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9dbe1960331f, replyNumber=0, likeNumber=46, createdTime=2020-06-19, rootId=0, userName=ms6980045490879608, userId=36f02500138, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9dbe1960331f, moduleTitle=FDA：批准司库奇尤单抗（可善挺）获治疗中轴型脊柱关节炎, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9dbe1960331f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1337845, encodeId=6bf1133e84570, content=<a href='/topic/show?id=165638446af' target=_blank style='color:#2F92EE;'>#可善挺#</a>, objectTitle=可善挺（司库奇尤单抗）强直性脊柱炎适应症获批, objectType=article, longId=193217, objectId=d1c619321e2d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d1c619321e2d, replyNumber=0, likeNumber=35, createdTime=2020-05-01, rootId=0, userName=ms6980045490879608, userId=36f02500138, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d1c619321e2d, moduleTitle=可善挺（司库奇尤单抗）强直性脊柱炎适应症获批, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d1c619321e2d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

可善挺

2020-05-29

ms6980045490879608 (审核中...)

前往app查看评论内容

#可善挺#

可善挺项目

2020-12-17

ms6980045490879608 (审核中...)

前往app查看评论内容

#可善挺#

FDA：批准司库奇尤单抗（可善挺）获治疗中轴型脊柱关节炎

2020-06-19

ms6980045490879608 (审核中...)

前往app查看评论内容

#可善挺#

可善挺（司库奇尤单抗）强直性脊柱炎适应症获批

2020-05-01

科室
- - 订阅+
  - 更多科室
工具
服务